Investments

Laboratoires Anios is present in more than 80 countries with different business units addressing notably the healthcare segment, through hospitals, clinics, and healthcare professionals. Laboratoires Anios is also present in food-processing, cosmetics, and pharmaceutics industries, as well as in the communities linked to accommodation and catering. International build up acquisitions will form the heart of the company’s growth strategy, which will be supported by ongoing investment, notably in R&D.

Limacorporate is a global leader in the design, production and distribution of orthopaedic devices. Founded by the Lualdi family in 1945, the group has now 600 employers and three production facilities in Italy. In 2011 it had revenues of 117 million euros, 66% of which was generated in markets outside of Italy. The strategic growth plan for Limacorporate SpA is focused on the further international expansion of the Group and on the enlargement of its existing product portfolio.

Riemser is a specialty pharmaceutical company, headquartered in Greifswald, Germany. Riemser operates internationally and has a primary focus on the sales, marketing and lifecycle management of pharmaceutical products for niche therapeutic markets with high medical need in the fields of Oncology, Anti-Infectives and Dermatology.

Sequens is a producer of essential chemicals for use in everyday products. The group is structured across 3 divisions: Pharmaceutical & Cosmetics, Performance Chemicals and Mineral Specialties. Seqens is an industry leader across a wide range of products including aspirin, paracetamol, salicylic acid, para-aminophenol, soda ash, sodium bicarbonate, phenol and oxygenated solvents. It targets a set of five resilient and diversified end-markets including pharma & healthcare, food & feed, cosmetics, flavors & fragrances, home care and environment. Seqens serves 750 customers from 14 industrial sites located in Europe and Asia, and employs ~1,600 people.